Copyright Reports & Markets. All rights reserved.

Global OTC Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 OTC Drug Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Overview: Global OTC Drug Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Class A
      • 1.2.3 Class B
    • 1.3 Market Analysis by Application
      • 1.3.1 Overview: Global OTC Drug Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Hospital
      • 1.3.3 Clinic
      • 1.3.4 Household
    • 1.4 Overview of Global OTC Drug Market
      • 1.4.1 Global OTC Drug Market Status and Outlook (2015-2025)
      • 1.4.2 North America (United States, Canada and Mexico)
      • 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
      • 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      • 1.4.5 South America, Middle East & Africa
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Bayer HealthCare
      • 2.1.1 Bayer HealthCare Details
      • 2.1.2 Bayer HealthCare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Bayer HealthCare SWOT Analysis
      • 2.1.4 Bayer HealthCare Product and Services
      • 2.1.5 Bayer HealthCare OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Bristol Myers Squibb
      • 2.2.1 Bristol Myers Squibb Details
      • 2.2.2 Bristol Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Bristol Myers Squibb SWOT Analysis
      • 2.2.4 Bristol Myers Squibb Product and Services
      • 2.2.5 Bristol Myers Squibb OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Pfizer
      • 2.3.1 Pfizer Details
      • 2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Pfizer SWOT Analysis
      • 2.3.4 Pfizer Product and Services
      • 2.3.5 Pfizer OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 GlaxoSmithKline (GSK)
      • 2.4.1 GlaxoSmithKline (GSK) Details
      • 2.4.2 GlaxoSmithKline (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 GlaxoSmithKline (GSK) SWOT Analysis
      • 2.4.4 GlaxoSmithKline (GSK) Product and Services
      • 2.4.5 GlaxoSmithKline (GSK) OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 BioGaia
      • 2.5.1 BioGaia Details
      • 2.5.2 BioGaia Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 BioGaia SWOT Analysis
      • 2.5.4 BioGaia Product and Services
      • 2.5.5 BioGaia OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Johnson&Johnson
      • 2.6.1 Johnson&Johnson Details
      • 2.6.2 Johnson&Johnson Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Johnson&Johnson SWOT Analysis
      • 2.6.4 Johnson&Johnson Product and Services
      • 2.6.5 Johnson&Johnson OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Chr. Hansen
      • 2.7.1 Chr. Hansen Details
      • 2.7.2 Chr. Hansen Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Chr. Hansen SWOT Analysis
      • 2.7.4 Chr. Hansen Product and Services
      • 2.7.5 Chr. Hansen OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 AstraZeneca
      • 2.8.1 AstraZeneca Details
      • 2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 AstraZeneca SWOT Analysis
      • 2.8.4 AstraZeneca Product and Services
      • 2.8.5 AstraZeneca OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Sanofi
      • 2.9.1 Sanofi Details
      • 2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Sanofi SWOT Analysis
      • 2.9.4 Sanofi Product and Services
      • 2.9.5 Sanofi OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Bukwang Pharmaceutica
      • 2.10.1 Bukwang Pharmaceutica Details
      • 2.10.2 Bukwang Pharmaceutica Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Bukwang Pharmaceutica SWOT Analysis
      • 2.10.4 Bukwang Pharmaceutica Product and Services
      • 2.10.5 Bukwang Pharmaceutica OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 DSM
      • 2.11.1 DSM Details
      • 2.11.2 DSM Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 DSM SWOT Analysis
      • 2.11.4 DSM Product and Services
      • 2.11.5 DSM OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Herbalife
      • 2.12.1 Herbalife Details
      • 2.12.2 Herbalife Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Herbalife SWOT Analysis
      • 2.12.4 Herbalife Product and Services
      • 2.12.5 Herbalife OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 Cipla
      • 2.13.1 Cipla Details
      • 2.13.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 Cipla SWOT Analysis
      • 2.13.4 Cipla Product and Services
      • 2.13.5 Cipla OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 Eisai
      • 2.14.1 Eisai Details
      • 2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 Eisai SWOT Analysis
      • 2.14.4 Eisai Product and Services
      • 2.14.5 Eisai OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.15 Friggs
      • 2.15.1 Friggs Details
      • 2.15.2 Friggs Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.15.3 Friggs SWOT Analysis
      • 2.15.4 Friggs Product and Services
      • 2.15.5 Friggs OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.16 CoLucid
      • 2.16.1 CoLucid Details
      • 2.16.2 CoLucid Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.16.3 CoLucid SWOT Analysis
      • 2.16.4 CoLucid Product and Services
      • 2.16.5 CoLucid OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.17 Euradite
      • 2.17.1 Euradite Details
      • 2.17.2 Euradite Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.17.3 Euradite SWOT Analysis
      • 2.17.4 Euradite Product and Services
      • 2.17.5 Euradite OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.18 Eli Lilly
      • 2.18.1 Eli Lilly Details
      • 2.18.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.18.3 Eli Lilly SWOT Analysis
      • 2.18.4 Eli Lilly Product and Services
      • 2.18.5 Eli Lilly OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.19 Daiichi Sankyo
      • 2.19.1 Daiichi Sankyo Details
      • 2.19.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.19.3 Daiichi Sankyo SWOT Analysis
      • 2.19.4 Daiichi Sankyo Product and Services
      • 2.19.5 Daiichi Sankyo OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

    3 Sales, Revenue and Market Share by Manufacturer

    • 3.1 Global OTC Drug Sales and Market Share by Manufacturer (2018-2019)
    • 3.2 Global OTC Drug Revenue and Market Share by Manufacturer (2018-2019)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 OTC Drug Manufacturer Market Share in 2019
      • 3.3.2 Top 6 OTC Drug Manufacturer Market Share in 2019
    • 3.4 Market Competition Trend

    4 Global Market Analysis by Regions

    • 4.1 Global OTC Drug Sales, Revenue and Market Share by Regions
      • 4.1.1 Global OTC Drug Sales and Market Share by Regions (2015-2020)
      • 4.1.2 Global OTC Drug Revenue and Market Share by Regions (2015-2020)
    • 4.2 North America OTC Drug Sales and Growth Rate (2015-2020)
    • 4.3 Europe OTC Drug Sales and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific OTC Drug Sales and Growth Rate (2015-2020)
    • 4.5 South America OTC Drug Sales and Growth Rate (2015-2020)
    • 4.6 Middle East and Africa OTC Drug Sales and Growth Rate (2015-2020)

    5 North America by Country

    • 5.1 North America OTC Drug Sales, Revenue and Market Share by Country
      • 5.1.1 North America OTC Drug Sales and Market Share by Country (2015-2020)
      • 5.1.2 North America OTC Drug Revenue and Market Share by Country (2015-2020)
    • 5.2 United States OTC Drug Sales and Growth Rate (2015-2020)
    • 5.3 Canada OTC Drug Sales and Growth Rate (2015-2020)
    • 5.4 Mexico OTC Drug Sales and Growth Rate (2015-2020)

    6 Europe by Country

    • 6.1 Europe OTC Drug Sales, Revenue and Market Share by Country
      • 6.1.1 Europe OTC Drug Sales and Market Share by Country (2015-2020)
      • 6.1.2 Europe OTC Drug Revenue and Market Share by Country (2015-2020)
    • 6.2 Germany OTC Drug Sales and Growth Rate (2015-2020)
    • 6.3 UK OTC Drug Sales and Growth Rate (2015-2020)
    • 6.4 France OTC Drug Sales and Growth Rate (2015-2020)
    • 6.5 Russia OTC Drug Sales and Growth Rate (2015-2020)
    • 6.6 Italy OTC Drug Sales and Growth Rate (2015-2020)

    7 Asia-Pacific by Regions

    • 7.1 Asia-Pacific OTC Drug Sales, Revenue and Market Share by Regions
      • 7.1.1 Asia-Pacific OTC Drug Sales and Market Share by Regions (2015-2020)
      • 7.1.2 Asia-Pacific OTC Drug Revenue and Market Share by Regions (2015-2020)
    • 7.2 China OTC Drug Sales and Growth Rate (2015-2020)
    • 7.3 Japan OTC Drug Sales and Growth Rate (2015-2020)
    • 7.4 Korea OTC Drug Sales and Growth Rate (2015-2020)
    • 7.5 India OTC Drug Sales and Growth Rate (2015-2020)
    • 7.6 Southeast Asia OTC Drug Sales and Growth Rate (2015-2020)
    • 7.7 Australia OTC Drug Sales and Growth Rate (2015-2020)

    8 South America by Country

    • 8.1 South America OTC Drug Sales, Revenue and Market Share by Country
      • 8.1.1 South America OTC Drug Sales and Market Share by Country (2015-2020)
      • 8.1.2 South America OTC Drug Revenue and Market Share by Country (2015-2020)
    • 8.2 Brazil OTC Drug Sales and Growth Rate (2015-2020)
    • 8.3 Argentina OTC Drug Sales and Growth Rate (2015-2020)

    9 Middle East & Africa by Countries

    • 9.1 Middle East & Africa OTC Drug Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East & Africa OTC Drug Sales and Market Share by Country (2015-2020)
      • 9.1.2 Middle East & Africa OTC Drug Revenue and Market Share by Country (2015-2020)
    • 9.2 Saudi Arabia OTC Drug Sales and Growth Rate (2015-2020)
    • 9.3 Turkey OTC Drug Sales and Growth Rate (2015-2020)
    • 9.4 Egypt OTC Drug Sales and Growth Rate (2015-2020)
    • 9.5 South Africa OTC Drug Sales and Growth Rate (2015-2020)

    10 Market Segment by Type

    • 10.1 Global OTC Drug Sales and Market Share by Type (2015-2020)
    • 10.2 Global OTC Drug Revenue and Market Share by Type (2015-2020)
    • 10.3 Global OTC Drug Price by Type (2015-2020)

    11 Global OTC Drug Market Segment by Application

    • 11.1 Global OTC Drug Sales Market Share by Application (2015-2020)
    • 11.2 Global OTC Drug Revenue Market Share by Application (2015-2020)
    • 11.3 Global OTC Drug Price by Application (2015-2020)

    12 Market Forecast

    • 12.1 Global OTC Drug Sales, Revenue and Growth Rate (2021-2025)
    • 12.2 OTC Drug Market Forecast by Regions (2021-2025)
      • 12.2.1 North America OTC Drug Market Forecast (2021-2025)
      • 12.2.2 Europe OTC Drug Market Forecast (2021-2025)
      • 12.2.3 Asia-Pacific OTC Drug Market Forecast (2021-2025)
      • 12.2.4 South America OTC Drug Market Forecast (2021-2025)
      • 12.2.5 Middle East & Africa OTC Drug Market Forecast (2021-2025)
    • 12.3 OTC Drug Market Forecast by Type (2021-2025)
      • 12.3.1 Global OTC Drug Sales Forecast by Type (2021-2025)
      • 12.3.2 Global OTC Drug Market Share Forecast by Type (2021-2025)
    • 12.4 OTC Drug Market Forecast by Application (2021-2025)
      • 12.4.1 Global OTC Drug Sales Forecast by Application (2021-2025)
      • 12.4.2 Global OTC Drug Market Share Forecast by Application (2021-2025)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology
      • 15.2 Data Source
      • 15.3 Disclaimer

      Market Overview
      The global OTC Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

      The OTC Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      OTC Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

      By Type, OTC Drug market has been segmented into
      Class A
      Class B

      By Application, OTC Drug has been segmented into:
      Hospital
      Clinic
      Household

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global OTC Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level OTC Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global OTC Drug market.

      The report offers in-depth assessment of the growth and other aspects of the OTC Drug market in important countries (regions), including:
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, etc.)
      Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

      Competitive Landscape and OTC Drug Market Share Analysis
      OTC Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, OTC Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the OTC Drug sales, revenue and market share for each player covered in this report.

      The major players covered in OTC Drug are:
      Bayer HealthCare
      Bristol Myers Squibb
      Pfizer
      GlaxoSmithKline (GSK)
      BioGaia
      Johnson&Johnson
      Chr. Hansen
      AstraZeneca
      Sanofi
      Bukwang Pharmaceutica
      DSM
      Herbalife
      Cipla
      Eisai
      Friggs
      CoLucid
      Euradite
      Eli Lilly
      Daiichi Sankyo

      Among other players domestic and global, OTC Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe OTC Drug product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of OTC Drug, with price, sales, revenue and global market share of OTC Drug in 2018 and 2019.
      Chapter 3, the OTC Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the OTC Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
      Chapter 12, OTC Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
      Chapter 13, 14 and 15, to describe OTC Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now